Delivery Order SPE2DB20D9214-SPE2DB25FD4XK
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a specific product fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $6,848.92 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injectors. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a discrete purchase under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with DLA valued at...
- The Defense Logistics Agency awarded a delivery order valued at $27,395.68 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector medications. This firm fixed-price delivery order was issued on August 19, 2025, with an ultimate completion date of September 10, 2025, and does not utilize a set-aside designation. The award represents a specific fulfillment under DMS Pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for Xolair 300 mg/2 mL auto-injector vials valued at $3,424.46. The award, issued on September 3, 2025, with a completion date of September 24, 2025, represents a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group, based in Park Ridge, Illinois, will perform the delivery at its location. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 mL auto-injector vials. This firm fixed-price delivery order, issued on August 25, 2025, with an ultimate completion date of September 16, 2025, represents a specific pharmaceutical procurement supporting military healthcare operations. The award carries no...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc. for Xolair 300 mg/2 mL auto-injector syringes on August 19, 2025, with an ultimate completion date of September 10, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a specific pharmaceutical product requirement to be delivered to Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.69 to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a continuation of the agency's pharmaceutical supply chain operations. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The delivery order is for Xolair 300 mg/2 ml auto-injectors and is part of a larger $499,999,999 indefinite delivery contract (IDC) under the SPE2DB program that DMS Pharmaceutical Group holds with DLA. This IDC enables DLA to issue delivery orders for a comprehensive range of pharmaceutical products,...
- The Defense Logistics Agency awarded a delivery order valued at $10,273.38 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on September 9, 2025, carries an ultimate completion date of September 30, 2025, with no set-aside designation applied. The contract represents a discrete fulfillment under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $17,122.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on August 29, 2025, is scheduled for completion by September 22, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS...
- SPE2DB20D9214Indefinite Delivery Contract
- SPE2DB20D9214-SPE2DB25FD4XKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 24, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company, which has been registered in the System for Award Management since 2001, specializes in distributing pharmaceutical products to federal agencies and military healthcare facilities nationwide, with no set-aside designation applied to this award. This delivery order is issued under the DLA's SPE2DB program, through which DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract valued at $499,999,999 and valid through November 2026. The SPE2DB vehicle enables the agency to procure a comprehensive range of pharmaceutical items, including prescription medications, biologics, and specialty auto-injectors, to support medical supply requirements across Department of Defense healthcare facilities globally. Through this framework, DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized medical products including oncology treatments, vaccines, and other prescription pharmaceuticals to military health systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.4k | 9/3/25 |